Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

Overview of attention for article published in Frontiers in oncology, October 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 10,966 followers.

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors https://t.co/hvumw9wuPO

20 Aug 2021

Reply Repost Favourite

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors ... https://t.co/hvumw9wuPO

29 Apr 2021

Reply Repost Favourite

New research: Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors: Body composition refers to the proportional content of body fat mass and lean body… https://t.c

26 Nov 2020

Reply Repost Favourite

Excited to share our comprehensive review!!! Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors https://t.co/JLGqwDhsJ6

29 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.